A blood test may catch the first warning signs of ovarian cancer
Finding ovarian cancer's warning signs before the disease develops could give high-risk women clearer information for making hard choices about prevention.
November 14, 2026
Ovarian cancer is often found only after it has already spread, which makes it hard to treat. A new study published in Nature Medicine points to another path: spotting the warning signs before a cancer has even formed.
For women at high risk, this could transform how we approach prevention.
The disease frequently starts as tiny precancerous lesions in the tissue of the fallopian tubes. A team led by Rajan Gogna at California's Hoag Family Cancer Institute found that women with these lesions carry higher amounts of a specific RNA molecule in their blood.
When the researchers measured that molecule, they picked up the lesions in 92.3% of the women who had them, and correctly cleared 98.2% of healthy women. For women with genetic risk factors, positive results would be right in approximately 72% of cases, and a negative result would hold true nearly 100% of the time.
This could matter a great deal for women at high risk, who often have to decide whether to have their fallopian tubes and ovaries taken out based on inherited risk alone. Co-author Dr Esha Madan says the test might one day show whether precancerous changes are truly present.